Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Genet Mol Res ; 15(2)2016 Apr 04.
Article in English | MEDLINE | ID: mdl-27173192

ABSTRACT

Many microRNAs (miRNAs) exhibit altered expression levels in cancers, and they may be considered as valuable prognostic biomarkers for cancers. Here we aimed to summarize the recent advances in miR-10b involvement in human breast cancer and analyze the predicting role of miR-10b for survival. We searched, Embase, and Wanfang databases to identify studies on the prognostic role of miR-10b expression in breast cancer. A total of 770 patients from 7 eligible studies were included in the analysis. Pooled risk ratios (RRs) with 95% confidence interval (95%CI) were calculated to estimate the effect. Our results showed that high miR-10b expression in patients with breast cancer was significantly associated with poor disease-free survival (DFS) (RR = 1.53; 95%CI = 1.06-2.21; P = 0.02). However, no significant association between miR-10b and overall survival was found in overall studies. Subgroup analysis indicated that high expression of miR-10b was significantly correlated with DFS in Asia (RR = 2.94; 95%CI = 1.71-5.05). The present meta-analysis demonstrated that high expression of miR-10b might predict poor survival in patients with breast cancer. Larger clinical studies are required to further evaluate the role of miR-10b in clinical practice.


Subject(s)
Biomarkers, Tumor/genetics , Breast Neoplasms/genetics , MicroRNAs/genetics , Adult , Aged , Aged, 80 and over , Biomarkers, Tumor/metabolism , Breast Neoplasms/pathology , Case-Control Studies , Female , Humans , MicroRNAs/metabolism , Middle Aged , Up-Regulation
2.
Genet Mol Res ; 14(3): 10743-51, 2015 Sep 09.
Article in English | MEDLINE | ID: mdl-26400303

ABSTRACT

Pathological scar tissues and normal skin tissues were differentiated by screening for differentially expressed genes in pathologic scar tissues via gene expression microarray. The differentially expressed gene data was analyzed by gene ontology and pathway analyses. There were 5001 up- or down-regulated genes in 2-fold differentially expressed genes, 956 up- or down-regulated genes in 5-fold differentially expressed genes, and 114 up- or down-regulated genes in 20-fold differentially expressed genes. Therefore, significant differences were observed in the gene expression in pathological scar tissues and normal foreskin tissues. The development of pathological scar tissues has been correlated to changes in multiple genes and pathways, which are believed to form a dynamic network connection.


Subject(s)
Cicatrix/genetics , Folliculitis/genetics , Furunculosis/genetics , Proteins/genetics , Adult , Cicatrix/etiology , Cicatrix/metabolism , Cicatrix/pathology , Folliculitis/complications , Folliculitis/metabolism , Folliculitis/pathology , Foreskin/cytology , Foreskin/metabolism , Furunculosis/complications , Furunculosis/metabolism , Furunculosis/pathology , Gene Expression Profiling , Gene Expression Regulation , Gene Ontology , Humans , Male , Metabolic Networks and Pathways/genetics , Molecular Sequence Annotation , Oligonucleotide Array Sequence Analysis , Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL